Q
Queensland Eye Institute | Woolloongabba QEI Clinic, Woolloongabba, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ranibizumab
Faricimab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
Study WR42221 is a Phase IIIb, global, multicenter, randomized, visual assessor-masked study designed to assess the efficacy, safety, and pharmacokin...
Enrolling
Neovascular Age-related Macular Degeneration (nAMD)
Device: Port Delivery System with Ranibizumab
Drug: Ranibizumab
This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.
Active, not recruiting
Diabetic Macular Edema
Drug: Faricimab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems